Business Context and Reporting Period
Company: Research Solutions, Inc. (RSSS)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended December 31, 2025
Business Overview: A vertical SaaS and AI company providing research intelligence platforms (Discovery, Access, Manage) and transactional delivery of scientific, technical, and medical (STM) content. The company operates as a single segment and is a smaller reporting company.
Key Financial Metrics
| Metric | Three Months Ended Dec 31, 2025 | Six Months Ended Dec 31, 2025 |
|---|---|---|
| Total Revenue | $11.79 million | $24.10 million |
| Gross Profit | $6.18 million | $12.40 million |
| Gross Margin | 52.4% | 51.5% |
| Net Income (Loss) | $0.55 million | $1.30 million |
| Diluted EPS | $0.02 | $0.04 |
| Operating Cash Flow | N/A | $2.49 million |
| Cash and Equivalents | $12.26 million (Dec 31, 2025) | $12.26 million (Dec 31, 2025) |
| Total Liabilities | $27.02 million | $27.02 million |
| Stockholders' Equity | $17.23 million | $17.23 million |
Material Changes vs. Prior Period
- Revenue: Total revenue was relatively flat for the three months ended Dec 31, 2025 (-1.0% YoY) and increased slightly for the six months (+0.6% YoY). This was driven by a 13.6% increase in Platform revenue (due to new deployments and cross-selling Scite) offset by a 10.2% decline in Transaction revenue (due to lower paid order volume).
- Profitability: The company returned to profitability, reporting Net Income of $0.55 million for the quarter and $1.30 million for the six months, compared to Net Losses of $1.98 million and $1.31 million in the prior year periods, respectively.
- Key Driver: The significant improvement in net income is primarily attributed to a reduced loss from the change in fair value of the contingent earnout liability related to the Scite acquisition ($0.28 million loss in Q2 2025 vs. $2.41 million loss in Q2 2024).
- Operating Expenses: Total operating expenses decreased by 5.1% for the quarter and 1.3% for the six months, largely due to a 60.1% reduction in stock-based compensation expense.
- Liquidity: Cash and cash equivalents remained stable at approximately $12.26 million. The company has a $500,000 revolving line of credit with PNC Bank, which remains undrawn.
Outlook, Risks, and Unusual Items
- Contingent Earnout Liability: A significant portion of the company's liabilities ($10.7 million as of Dec 31, 2025) relates to the Scite acquisition earnout. The liability is valued using Level 3 inputs. Payments are being made in installments of cash and stock through May 2027. Fluctuations in the fair value of this liability significantly impact reported net income.
- Stock-Based Compensation: The company continues to utilize stock options and restricted stock awards. Unrecognized compensation costs for unvested options and restricted stock total approximately $1.26 million as of Dec 31, 2025.
- Revenue Mix: Management is focusing on growing high-margin Platform revenue (SaaS subscriptions) while Transaction revenue (single article delivery) faces volume headwinds.
- Risk Factors: The filing notes no material changes to risk factors from the previous 10-K. Key risks include reliance on third-party content publishers, foreign currency fluctuations (costs in Mexican Pesos), and the ability to maintain growth in the competitive AI and research software market.
- Subsequent Events: On February 2, 2026, the company completed the third installment of the Scite earnout payment, consisting of $1.2 million in cash and 252,146 shares of common stock.
Investor Verification Checklist
- Earnout Liability Valuation: Verify the assumptions used to value the $10.7 million contingent earnout liability, as changes in this estimate drive significant volatility in net income.
- Platform vs. Transaction Growth: Monitor the trajectory of Platform revenue growth to ensure it continues to offset declines in Transaction volume.
- Cash Burn vs. Generation: Confirm that operating cash flow remains positive despite the large cash outflows required for earnout payments ($2.55 million paid in the first six months of FY2026).
- Stock Repurchase Program: Review the remaining authorization ($122,767) for share repurchases to satisfy tax withholding obligations and its impact on share count.
- Customer Concentration: Verify that no single customer represents more than 10% of revenue or accounts receivable, as disclosed in the filing.